FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

HAWKINS ELMA

2. Date of Event Requiring Statement (MM/DD/YYYY)
8/21/2014 

3. Issuer Name and Ticker or Trading Symbol

Lion Biotechnologies, Inc. [LBIO]

(Last)        (First)        (Middle)

21900 BURBANK BLVD., THIRD FLOOR

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
President & COO /

(Street)

WOODLAND HILLS, CA 91367       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   555   D    
Common Stock   47000   I   By spouse  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock option (right to buy)     (1) 2/21/2019   Common Stock   200000   $5.65   D    
Restricted Stock     (2)   (2) Common Stock   200000   $0   D    
Warrant   11/5/2013   11/5/2018   Common Stock   50000   $2.5   I   By spouse  

Explanation of Responses:
( 1)  The option will vest as to 66,666 shares on February 21, 2015, and the remaining 133,334 shares will vest in eight equal quarterly installments over the two years after February 21, 2015, provided the Reporting Person is still providing services to the Issuer on the respective dates.
( 2)  The restricted stock will vest as to 40,000 shares on February 28, 2015, as to 60,000 shares on February 28, 2016 and as to 100,000 shares on February 28, 2017, provided the Reporting Person is still providing services to the Issuer on the respective dates.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
HAWKINS ELMA
21900 BURBANK BLVD., THIRD FLOOR
WOODLAND HILLS, CA 91367

President & COO

Signatures
/s/ Elma Hawkins 9/17/2014
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.